1. FRI0303 Efficacy and safety of ustekinumab in patients with active systemic lupus erythematosus: results of a phase 2, randomised placebo-controlled study. (12th June 2018) Authors: van Vollenhoven, R.; Hahn, B.H.; Tsokos, G.C.; Wagner, C.; Lipsky, P.; Hsu, B.; Chevrier, M.; Gordon, R.; Triebel, M.; Rose, S. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗